{"id":483826,"date":"2021-04-28T16:48:17","date_gmt":"2021-04-28T20:48:17","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\/"},"modified":"2021-04-28T16:48:17","modified_gmt":"2021-04-28T20:48:17","slug":"shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\/","title":{"rendered":"Shattuck Labs Announces Participation in the 7th Annual Truist Securities Life Sciences Summit"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">AUSTIN, Texas and DURHAM, N.C., April  28, 2021  (GLOBE NEWSWIRE) &#8212; Shattuck Labs, Inc. (Shattuck) (NASDAQ: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PZSgjbUB3x15y0qLhr2aqceIkyeCr7nVnQG_CEyCWqxnr-eBRn6U_jyoWYgoOEAvYabtp7FsOyEyoWsFG9PbBA==\" rel=\"nofollow noopener\" target=\"_blank\">STTK<\/a>), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,\u00a0today announced it will participate in the 7<sup>th<\/sup> Annual Truist Securities Life Sciences Summit being held virtually May 4-5, 2021.<\/p>\n<p>\n        <strong>Presentation Details<\/strong><br \/>\n        <br \/>Conference: 7<sup><strong>th<\/strong><\/sup> Annual Truist Securities Life Sciences Summit<br \/>Format: Fireside chat with analyst Asthika Goonewardene<br \/>Presenters: Taylor Schreiber, M.D., Ph.D., Shattuck\u2019s Chief Executive Officer and Andrew Neill, Shattuck\u2019s Chief Financial Officer<br \/>Date: May 5, 2021<br \/>Time: 1:50 p.m. EST<br \/>Webcast Link: Available <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JReUAR0__H33hrKpfIw6YxZ4rBVtPYWbcjHxv6vk2KiGEz8mDHjYcar2Zs4hYUFaqFljNE-cAtbLbMmsA9HID3ZeFYbgbmjkF-hZe65oqoX3E3sTAFW8V0mXCzO9cf0G\" rel=\"nofollow noopener\" target=\"_blank\">Here<\/a><\/p>\n<p>A live webcast will be available on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5q1m_jR5xLmPlrNVCXz-6nSM7EzdhGaOdDWvxoZhwRsHSNMPUOG5fEp0mH-_KtL7dBWto3PnfeyQ5AIyikxrCnivsGjWCNHKLnukedemybrlA-KaPrIt0KXaSmtoJStYuQS-VMhdvlXyhKjeccsKpfacBZep9QKhDOrhTw1ND2Y=\" rel=\"nofollow noopener\" target=\"_blank\">Events\u00a0&amp; Presentations<\/a> section of the Company\u2019s website. A replay of the webcast will be archived for up to 90 days following the presentation date.<\/p>\n<p>\n        <strong>About Shattuck Labs, Inc.<\/strong><br \/>\n        <br \/>Shattuck is a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Compounds derived from Shattuck\u2019s proprietary Agonist Redirected Checkpoint, ARC<sup>\u00ae<\/sup>, platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic. The company\u2019s lead wholly owned program, SL-172154 (SIRP\u03b1-Fc-CD40L), which is designed to block the CD47 immune checkpoint and simultaneously agonize the CD40 pathway, is being evaluated in a Phase 1 trial. A second compound, SL-279252 (PD1-Fc-OX40L), is being evaluated in a Phase 1 trial in collaboration with\u00a0Takeda Pharmaceuticals. Additionally, the company is advancing a proprietary Gamma Delta T Cell Engager, GADLEN\u2122, platform, which is designed to bridge gamma delta T cells to tumor antigens for the treatment of patients with cancer. Shattuck has offices in both\u00a0Austin, Texas and Durham, North Carolina. For more information, please visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=M_DVZMZqpefsrCNtinDd-je0E5KfPjtCB-v04ya-Ffm6Vro-Up4NeXclKYYNXk5JjyUQdcoIofyWkOhzKS4lCKLqnvNNwWHX9ZpyQ1kzEng=\" rel=\"nofollow noopener\" target=\"_blank\">www.ShattuckLabs.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact: <\/strong><br \/>\n        <br \/>Conor Richardson<br \/>Senior Director, Finance &amp; Investor Relations<br \/>Shattuck Labs, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6Zd96enu9N83SxKGctaIJLA5QJPzRSf6-GZOqKXvxOiiBnUV7jhaHAIZ5fkDeynsOAAgL6W0Qa62lKgJkUnHWJBmaMZN1_9VEg2IkbDqNGIBlywkggIVdxqACQXfuEsuHYbRtnCR-DAcceiLgOYAVw==\" rel=\"nofollow noopener\" target=\"_blank\">InvestorRelations@shattucklabs.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Stephanie Ascher <br \/>Managing Director<br \/>Stern Investor Relations, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NjqmhRKoPSKNOf3po7y-fa1UsWsHV5un1SlN5kPNT796GQXB0sjGNmpf2FCVeHZd03vY3dBqGwmVVkbsn5JLTAqD9m1IpCfZjU-Wj4SeZ040G23Grf6zox4J92DOdvl0\" rel=\"nofollow noopener\" target=\"_blank\">Stephanie.ascher@sternir.com<\/a><\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTg2NCM0MTQ0ODk4IzIyMDI4MzE=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/381ab429-94b1-4ec6-922e-fb666f1464d3\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>AUSTIN, Texas and DURHAM, N.C., April 28, 2021 (GLOBE NEWSWIRE) &#8212; Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,\u00a0today announced it will participate in the 7th Annual Truist Securities Life Sciences Summit being held virtually May 4-5, 2021. Presentation Details Conference: 7th Annual Truist Securities Life Sciences SummitFormat: Fireside chat with analyst Asthika GoonewardenePresenters: Taylor Schreiber, M.D., Ph.D., Shattuck\u2019s Chief Executive Officer and Andrew Neill, Shattuck\u2019s Chief Financial OfficerDate: May 5, 2021Time: 1:50 p.m. ESTWebcast Link: Available Here A live webcast will be available on the Events\u00a0&amp; Presentations section of the Company\u2019s website. A &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Shattuck Labs Announces Participation in the 7th Annual Truist Securities Life Sciences Summit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-483826","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Shattuck Labs Announces Participation in the 7th Annual Truist Securities Life Sciences Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shattuck Labs Announces Participation in the 7th Annual Truist Securities Life Sciences Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"AUSTIN, Texas and DURHAM, N.C., April 28, 2021 (GLOBE NEWSWIRE) &#8212; Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,\u00a0today announced it will participate in the 7th Annual Truist Securities Life Sciences Summit being held virtually May 4-5, 2021. Presentation Details Conference: 7th Annual Truist Securities Life Sciences SummitFormat: Fireside chat with analyst Asthika GoonewardenePresenters: Taylor Schreiber, M.D., Ph.D., Shattuck\u2019s Chief Executive Officer and Andrew Neill, Shattuck\u2019s Chief Financial OfficerDate: May 5, 2021Time: 1:50 p.m. ESTWebcast Link: Available Here A live webcast will be available on the Events\u00a0&amp; Presentations section of the Company\u2019s website. A &hellip; Continue reading &quot;Shattuck Labs Announces Participation in the 7th Annual Truist Securities Life Sciences Summit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-28T20:48:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTg2NCM0MTQ0ODk4IzIyMDI4MzE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Shattuck Labs Announces Participation in the 7th Annual Truist Securities Life Sciences Summit\",\"datePublished\":\"2021-04-28T20:48:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\\\/\"},\"wordCount\":340,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTg2NCM0MTQ0ODk4IzIyMDI4MzE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\\\/\",\"name\":\"Shattuck Labs Announces Participation in the 7th Annual Truist Securities Life Sciences Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTg2NCM0MTQ0ODk4IzIyMDI4MzE=\",\"datePublished\":\"2021-04-28T20:48:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTg2NCM0MTQ0ODk4IzIyMDI4MzE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTg2NCM0MTQ0ODk4IzIyMDI4MzE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shattuck Labs Announces Participation in the 7th Annual Truist Securities Life Sciences Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Shattuck Labs Announces Participation in the 7th Annual Truist Securities Life Sciences Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\/","og_locale":"en_US","og_type":"article","og_title":"Shattuck Labs Announces Participation in the 7th Annual Truist Securities Life Sciences Summit - Market Newsdesk","og_description":"AUSTIN, Texas and DURHAM, N.C., April 28, 2021 (GLOBE NEWSWIRE) &#8212; Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,\u00a0today announced it will participate in the 7th Annual Truist Securities Life Sciences Summit being held virtually May 4-5, 2021. Presentation Details Conference: 7th Annual Truist Securities Life Sciences SummitFormat: Fireside chat with analyst Asthika GoonewardenePresenters: Taylor Schreiber, M.D., Ph.D., Shattuck\u2019s Chief Executive Officer and Andrew Neill, Shattuck\u2019s Chief Financial OfficerDate: May 5, 2021Time: 1:50 p.m. ESTWebcast Link: Available Here A live webcast will be available on the Events\u00a0&amp; Presentations section of the Company\u2019s website. A &hellip; Continue reading \"Shattuck Labs Announces Participation in the 7th Annual Truist Securities Life Sciences Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-28T20:48:17+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTg2NCM0MTQ0ODk4IzIyMDI4MzE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Shattuck Labs Announces Participation in the 7th Annual Truist Securities Life Sciences Summit","datePublished":"2021-04-28T20:48:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\/"},"wordCount":340,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTg2NCM0MTQ0ODk4IzIyMDI4MzE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\/","name":"Shattuck Labs Announces Participation in the 7th Annual Truist Securities Life Sciences Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTg2NCM0MTQ0ODk4IzIyMDI4MzE=","datePublished":"2021-04-28T20:48:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTg2NCM0MTQ0ODk4IzIyMDI4MzE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTg2NCM0MTQ0ODk4IzIyMDI4MzE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-announces-participation-in-the-7th-annual-truist-securities-life-sciences-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Shattuck Labs Announces Participation in the 7th Annual Truist Securities Life Sciences Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/483826","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=483826"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/483826\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=483826"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=483826"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=483826"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}